Carcinoid syndrome epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(39 intermediate revisions by 4 users not shown)
Line 3: Line 3:
{{CMG}}{{AE}}{{PSD}}
{{CMG}}{{AE}}{{PSD}}
==Overview==
==Overview==
The prevalence of carcinoid syndrome is approximately 1.5 per 100,000 individuals worldwide.
The [[Incidence rate|incidence]] of [[Carcinoid Syndrome|carcinoid syndrome]] is estimated to be 2 cases per 100,000 individuals worldwide. [[Carcinoid Syndrome|Carcinoid syndrome]] is a [[disease]] that tends to affect the [[elderly]] population. The median [[age]] at diagnosis is 60.9 years.Females are more commonly affected with [[Carcinoid Syndrome|carcinoid syndrome]] than males. [[Carcinoid Syndrome|Carcinoid syndrome]] usually affects individuals of the caucasian race. African American, Latin American, and Asian individuals are less likely to develop [[Carcinoid Syndrome|carcinoid syndrome]].
 
==Epidemiology and Demographics==
==Epidemiology and Demographics==
*Carcinoid syndrome is quite rare with a disease prevalence of 15 cases per 1,000,000 people.
===Prevalence===
*The age-adjusted incidence of carcinoid tumors worldwide is approximately 2 per 100,000 persons.  
*[[Carcinoid tumors]] represent about 0.5% of all newly diagnosed [[malignancies]].
*The average age at diagnosis is 61.4 years.  
*[[Carcinoid tumors]] account for 75% of all [[gastrointestinal]] [[endocrine tumors]].
*Carcinoid tumors represent about 0.5% of all newly diagnosed malignancies.
*[[Ovarian]] [[carcinoid tumors]] account for 0.3% of all [[Ovarian tumor|ovarian tumors]] and 0.5% of [[carcinoid tumors]].<ref>Ovarian carcinoid tumors. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/ovarian-carcinoid-tumours</ref>
*Carcinoid tumors account for 75% of all gastrointestinal endocrine tumors.
===Incidence===
*The incidence of [[Carcinoid Syndrome|carcinoid syndrome]] is estimated to be 2 cases per 100,000 individuals worldwide.<ref name="incidence">Epidemiology of carcinoid tumor. National cancer institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq</ref>
* [[Neuroendocrine tumor|Neuroendocrine tumors]] of the [[Digestive systems|digestive system]] arising in the [[Gastrointestinal|tubular gastrointestinal tract]] and the [[pancreas]] are relatively rare.
* The annual incidence in the United States is approximately 3.56 per 100,000 population.<ref name="pmid28448665">{{cite journal |vauthors=Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC |title=Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States |journal=JAMA Oncol |volume=3 |issue=10 |pages=1335–1342 |date=October 2017 |pmid=28448665 |pmc=5824320 |doi=10.1001/jamaoncol.2017.0589 |url=}}</ref>
 
===Age===
*[[Carcinoid Syndrome|Carcinoid syndrome]] is a [[disease]] that tends to affect th[[Elderly|e elderly p]]<nowiki/>opulation.<ref name="pmid15213627">{{cite journal| author=Maggard MA, O'Connell JB, Ko CY| title=Updated population-based review of carcinoid tumors. | journal=Ann Surg | year= 2004 | volume= 240 | issue= 1 | pages= 117-22 | pmid=15213627 | doi= | pmc=PMC1356383 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15213627  }} </ref>
*[[Ovarian]] [[carcinoid tumors]] are commonly seen in [[perimenopausal]] and [[postmenopausal]] [[women]].
*The median [[age]] at [[diagnosis]] is 60.9 years.<ref name="pmid15213627">{{cite journal| author=Maggard MA, O'Connell JB, Ko CY| title=Updated population-based review of carcinoid tumors. | journal=Ann Surg | year= 2004 | volume= 240 | issue= 1 | pages= 117-22 | pmid=15213627 | doi= | pmc=PMC1356383 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15213627  }} </ref>
 
===Gender===
*[[Females]] are more commonly affected with [[Carcinoid Syndrome|carcinoid syndrome]] than [[males]].
*[[Males]] are more commonly affected with [[thymic]] [[carcinoid tumor]] than females. The male to female ratio is approximately 3 to 1.<ref>Thymic carcinoid tumour. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/thymic-carcinoid-tumour</ref>
 
===Race===
*[[Carcinoid Syndrome|Carcinoid syndrome]] usually affects individuals of the Caucasian race.  
*African American, Latin American, and Asian individuals are less likely to develop [[Carcinoid Syndrome|carcinoid syndrome]].<ref name="pmid15213627">{{cite journal| author=Maggard MA, O'Connell JB, Ko CY| title=Updated population-based review of carcinoid tumors. | journal=Ann Surg | year= 2004 | volume= 240 | issue= 1 | pages= 117-22 | pmid=15213627 | doi= | pmc=PMC1356383 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15213627  }} </ref>


==References==
==References==
{{reflist|2}}
{{reflist|2}}


[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Types of cancer]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Gastroenterology]]
[[Category:Pulmonology]]
 
[[Category:Hematology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Endocrinology]]
[[Category:Surgery]]

Latest revision as of 20:35, 1 May 2019

Carcinoid syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoid Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoid syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoid syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoid syndrome epidemiology and demographics

CDC on Carcinoid syndrome epidemiology and demographics

Carcinoid syndrome epidemiology and demographics in the news

Blogs on Carcinoid syndrome epidemiology and demographics

Directions to Hospitals Treating Carcinoid syndrome

Risk calculators and risk factors for Carcinoid syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

The incidence of carcinoid syndrome is estimated to be 2 cases per 100,000 individuals worldwide. Carcinoid syndrome is a disease that tends to affect the elderly population. The median age at diagnosis is 60.9 years.Females are more commonly affected with carcinoid syndrome than males. Carcinoid syndrome usually affects individuals of the caucasian race. African American, Latin American, and Asian individuals are less likely to develop carcinoid syndrome.

Epidemiology and Demographics

Prevalence

Incidence

Age

Gender

Race

References

  1. Ovarian carcinoid tumors. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/ovarian-carcinoid-tumours
  2. Epidemiology of carcinoid tumor. National cancer institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq
  3. Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC (October 2017). "Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States". JAMA Oncol. 3 (10): 1335–1342. doi:10.1001/jamaoncol.2017.0589. PMC 5824320. PMID 28448665.
  4. 4.0 4.1 4.2 Maggard MA, O'Connell JB, Ko CY (2004). "Updated population-based review of carcinoid tumors". Ann Surg. 240 (1): 117–22. PMC 1356383. PMID 15213627.
  5. Thymic carcinoid tumour. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/thymic-carcinoid-tumour


Template:WikiDoc Sources